Discover
TIL
Instil Bio, Inc.
7.69
2 x 5.55
2 x 9.86
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
7.69 +0.00 (0.00%)
| Ytd | -30.09% | |
| 1y | -64.93% |
7.53
day range
7.81
5.67
52 week range
33.83
| Open | 7.71 | Prev Close | 7.69 | Low | 7.53 | High | 7.81 | Mkt Cap | 52.15M |
| Vol | 15.19K | Avg Vol | 25.49K | EPS | -7.00 | P/E | N/A | Forward P/E | -1.80 |
| Beta | 1.74 | Short Ratio | 2.29 | Inst. Own | 80.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-04 | 50-d Avg | 7.96 | 200-d Avg | 10.93 | 1yr Est | 100.33 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | -2.08 | -3.54 | -1.46 | -70.19% |
| 2024-08-13 | 2024-06 | -3.04 | -2.29 | 0.75 | 24.67% |
| 2024-08-13 | 2024-06 | -3.04 | N/A | N/A | N/A |
| 2024-05-10 | 2024-03 | -2.16 | N/A | N/A | N/A |
| 2024-05-10 | 2024-03 | -2.16 | -3.74 | -1.58 | -73.15% |
| 2024-03-21 | 2023-12 | 0 | -1.99 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-11-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-11-04 | JMP Securities | Upgrade | Market Perform | |
| 2024-09-17 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-09-16 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-09-16 | Baird | Upgrade | Outperform | Outperform |
Profile
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Curative Ventures V LLC | 1.90M | 41.25M | 29.10% |
| 2024-09-29 | Vivo Capital, LLC | 624.34K | 13.56M | 9.57% |
| 2024-09-29 | CPMG INC | 410.92K | 8.93M | 6.30% |
| 2024-09-29 | Boxer Capital, LLC | 355.50K | 7.72M | 5.45% |
| 2024-09-29 | Perceptive Advisors Llc | 345.55K | 7.51M | 5.29% |
| 2024-09-29 | BML Capital Management, LLC | 335.00K | 7.28M | 5.13% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 85.90K | 1.87M | 1.32% |
| 2024-09-29 | Invesco Main Street Small Cap Fund | 67.77K | 1.47M | 1.04% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 60.76K | 1.32M | 0.93% |
| 2024-09-29 | Invesco V.I. Main Street Small Cap Fund | 31.57K | 685.70K | 0.48% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 21.76K | 472.67K | 0.33% |
| 2024-09-29 | Massmutual Premier Small Cap Opportunities Fund | 14.44K | 313.62K | 0.22% |
Split
| Split | Date |
|---|---|
| 1 : 20 | 2023-12-08 |